These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32466563)

  • 21. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
    Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organic anion transport polypeptide 1b2 selectively affects the pharmacokinetic interaction between paclitaxel and sorafenib in rats.
    Ma X; Qin X; Shang X; Liu M; Wang X
    Biochem Pharmacol; 2019 Nov; 169():113612. PubMed ID: 31437461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
    Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells.
    Ban JO; Hwang CJ; Park MH; Hwang IK; Jeong HS; Lee HP; Hyun BK; Kim JY; Youn HS; Ham YW; Yoon DY; Han SB; Song MJ; Hong JT
    Arch Pharm Res; 2015 Jul; 38(7):1351-62. PubMed ID: 25791937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
    Kim HM; Kim SA; Park SB; Cho JH; Song SY
    Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
    Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
    Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
    Flaherty KT; Schiller J; Schuchter LM; Liu G; Tuveson DA; Redlinger M; Lathia C; Xia C; Petrenciuc O; Hingorani SR; Jacobetz MA; Van Belle PA; Elder D; Brose MS; Weber BL; Albertini MR; O'Dwyer PJ
    Clin Cancer Res; 2008 Aug; 14(15):4836-42. PubMed ID: 18676756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of antitumor effects of sorafenib and lapatinib alone and in combination on MCF-7 breast cancer cells.
    Kacan T; Altun A; Altun GG; Kacan SB; Sarac B; Seker MM; Bahceci A; Babacan N
    Asian Pac J Cancer Prev; 2014; 15(7):3185-9. PubMed ID: 24815468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib.
    Huang Y; Wang K; Gu C; Yu G; Zhao D; Mai W; Zhong Y; Liu S; Nie Y; Yang H
    Oncol Rep; 2018 Sep; 40(3):1525-1532. PubMed ID: 30015938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
    Tran MA; Smith CD; Kester M; Robertson GP
    Clin Cancer Res; 2008 Jun; 14(11):3571-81. PubMed ID: 18519791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.
    Johnston JS; Johnson A; Gan Y; Wientjes MG; Au JL
    Pharm Res; 2003 Jul; 20(7):957-61. PubMed ID: 12880279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo.
    Tan KT; Li S; Li YR; Cheng SL; Lin SH; Tung YT
    Appl Biochem Biotechnol; 2019 Apr; 187(4):1328-1343. PubMed ID: 30229430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
    Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation.
    Feng Y; Guo X; Huang X; Wu M; Li X; Wu S; Luo X
    Mol Med Rep; 2018 Oct; 18(4):3866-3872. PubMed ID: 30106125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogels as feeder-free scaffolds for long-term self-renewal of mouse induced pluripotent stem cells.
    Yang JJ; Liu JF; Kurokawa T; Kitada K; Gong JP
    J Tissue Eng Regen Med; 2015 Apr; 9(4):375-88. PubMed ID: 23166055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
    Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
    Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.